Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ratner

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
Molecular Cancer|June 7, 2021
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseasesMarcia Bellon, Izabela Bialuk, Veronica Galli, et al.
Communications Biology|March 27, 2019
Dynamic host immune response in virus-associated cancersSong Cao, Kristine M Wylie, Matt A Wyczalkowski, et al.
Cancer|January 30, 2014
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061Michelle A Rudek, Page C Moore, Ronald T Mitsuyasu, et al.
Oncotarget|October 21, 2017
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic miceAlison K Esser, Daniel A Rauch, Jingyu Xiang, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2025
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)Anuradha Krishnamurthy, Hong Wang, John C Rhee, et al.
Journal of Extracellular Vesicles|October 10, 2024
HTLV-1 infected T cells cause bone loss via small extracellular vesiclesNitin Kumar Pokhrel, Amanda R Panfil, Haniya Habib, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
HTLV-1 infected T cells cause bone loss via small extracellular vesiclesNitin Kumar Pokhrel, Amanda Panfil, Haniya Habib, et al.
Leukemia & Lymphoma|December 18, 2015
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy ConsortiumAriela Noy, Shelly Y Lensing, Page C Moore, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Plos Pathogens|May 21, 2021
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCFXiaogang Cheng, Ancy Joseph, Victor Castro, et al.
Molecular Cancer|June 7, 2021
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseasesMarcia Bellon, Izabela Bialuk, Veronica Galli, et al.
Communications Biology|March 27, 2019
Dynamic host immune response in virus-associated cancersSong Cao, Kristine M Wylie, Matt A Wyczalkowski, et al.
Cancer|January 30, 2014
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061Michelle A Rudek, Page C Moore, Ronald T Mitsuyasu, et al.
Oncotarget|October 21, 2017
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic miceAlison K Esser, Daniel A Rauch, Jingyu Xiang, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2025
Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406)Anuradha Krishnamurthy, Hong Wang, John C Rhee, et al.
Journal of Extracellular Vesicles|October 10, 2024
HTLV-1 infected T cells cause bone loss via small extracellular vesiclesNitin Kumar Pokhrel, Amanda R Panfil, Haniya Habib, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
HTLV-1 infected T cells cause bone loss via small extracellular vesiclesNitin Kumar Pokhrel, Amanda Panfil, Haniya Habib, et al.
Leukemia & Lymphoma|December 18, 2015
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy ConsortiumAriela Noy, Shelly Y Lensing, Page C Moore, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Pageof 15